Vol. 6 (08) pp. 1017-1021 DOI: 10.21474/IJAR01/7606

ASSOCIATION BETWEEN PLASMA VITAMIN D LEVEL AND METASTASIS IN BREAST CANCER.

, and
  • Biomedical Departement of Medical Faculty of Universitas Sumatera Utara.
  • Oncology Departement of Adam Malik Hospital Medan.
11 Downloads 51 Views
Crossref

Download Full Paper (PDF)

Abstract

Background: Metastasis is the leading cause of death in breast cancer. Experimental study found anti-invasive and anti-metastatic effects of vitamin D in cancer cells, but epidemiological studies supporting the anti-invasive and anti-metastatic effects of vitamin D are still inconsistent. The aim of the study was to investigate the association of plasma vitamin D levels and metastasis in breast cancer patients. Methods: A descriptive observational cross sectional study was performed on 50 newly diagnosed breast cancer patients at Adam Malik Hospital Medan. Plasma vitamin D levels were measured using enzyme-linked immunosorbent assay method. Chest x-ray, liver ultrasonography and fine-needle biopsy were performed to find cancer cell rmetastasis. The relationship between plasma vitamin D levels and metastases was analyzed by unpaired t-test. RESULTS: The mean plasma vitamin D levels in patients with positive distant metastatis and in patients with negative distant metastases were 26.900 ? 10.165 ng / ml and 27.561 ? 8.467 ng / ml. There were no association between plasma level vitamin D and metastasis in this study.

Keywords

Article Analytics

References

  1. Ajibade AA, Kirk JS, Karasik E, Gillard B, Mosser MT, et al. Early Growth Inhibition is followed by increased metastatic disease with vitamin D ( calcitriol ) treatment in the TRAMP model of prostate cancer. Plos One 2014; 9(2)
  2. Apoloslou P, Fostira F. Hereditary breast cancer : The era of new susceptibility genes. Biomed Research International 2013
  3. Anisiewicz A, Pawlik A, Filip-Psurska, Turlej E, Dzimira S, Milczarek M et al. Unvaforable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer. International Journal of Oncology 2018; 52:103 - 126
  4. Bodicoat DH,Schoemaker MJ, Jones ME, McFadden E, Griffin J, Asworth A, J. Timing of pubertal stages and breast cancer risk : The breakthrough generations study. 2014. Breast Cancer Research; 16:R18
  5. Chang K, Chen S, Yeh C, Pang J, Shen S, Hsu J, et al. Mart-10, a less calcemik vitamin D analog , is more potent than 1α,25-dihydroxyvitamin D3 inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro. The Journal of Steroid Biochemistry and Molecular Biology 2014; 139: 54-60
  6. Donepudi M, Kondapalli K, Apos J, Venkanteshan P. Breast cancer statistics and markers. Journal of cancer research and Therapeutics 2014; 10(3)
  7. Elzehery RR, Baiomy AA, Hegazy MA, Fares R, El-Gilani A, Hegazi R. Vitamin D status, receptor gene Bsm1(A/G) polymorphism and breast cancer in group of Egyptian females. The Egyptian Journal of Medical Human Genetics 2016,
  8. Jeon S, Shin E. 2018. Exploring vitamin D metabolism and function in cancer. Experimental and Molecular Medicine; 50:20
  9. Kim HJ, Lee YM, Ko BS, Lee JW, Yu JH, Son BH et al. Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer. Ann Surg Oncol 2011; 18 : 1830-1836
  10. Krishnan AV, Swami S, Feldman D. Vitamin D and breast cancer : Inhibition of estrogen synthesis and signaling. Journal of Steroid and Molecular Biology 2010; 121: 343-348
  11. Lambert AW, Pattabiraman DR, Weinberg RA. Emerging Biological Principles of Metastasis. Cell 2017; 168
  12. Sofi NY, Jain M, Seenu V, Kamal VK, Pandey R. Nutritional risk factor and status of serum 25(OH)D levels in patient with breast cancer : a case control study in India. The Journal of Steroid and Biochemistry and Molecular Biologi 2018; 175: 55-59
  13. Tazzite A, Jouhadi H, Saiss K, Benider A, Nadifi S, Relationship between family history of breast cancer and clinicopathological features in Moroccan patients. Ethiop J Health Sci. 2013; 23(2)
  14. Thanasittichai S, Chaiwerawattana A, Prasitthipayong A. Association Of Vitamin D level with clinicopathological Features in breast cancer. Asian Pacific Journal of Cancer Prevention 2015; 16
  15. Wang Y, Zhu J, DeLuca HF. Where is vitamin D receptor ? Archives of Biochemistry and Biophysics 2012; 532: 123-133
  16. Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng TD, Hong C. Higher serum level of vitamin D at diagnosis are associated with better survival in prospective cohort of 1666 women with breast cancer : A case-cohort analysis in pathways study. JAMA Oncol 2017; 3(3): 351-357
  17. Williams JD, Aggarwal A, Swami S, Krishnan AV, Ji L, Albertelli MA, Feldman BJ. Tumor autonomous effects of vitamin D defisciency promote breast cancer metastasis. Endocrinology 2016;157(4): 1341-1347
  18. Wu Y, Sarkissyan M, Clayton S, Chlebowski R, Vadgama J. Association of vitamin D3 level with breast cancer risk and prognosis in African-American and Hispanic Women. Cancers 2017;9:144
  19. Wu X, Zhou T, Cao N, Ni J, Wang X. Role of vitamin D metabolism and activity on carcinogenesis. Oncology Research 2015; 22: 129-137
  20. Zhalehjoo N, Shakiba Y, Panjehpour M. Gene expression profiles of CYP24A1 and CYP27B1 in malignant and normal breast tissue. Molecular Medicine Reports 2017; 15: 467-473
  21. Zhang X, Harbeck N, Jeschke U, Doisneau-Sixou S. Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer. J Cancer Res Clin Oncol 2017;143:1107-1122.

How to Cite This Article

Ira Astuti Hasibuan, Sry Suryani Widjaja and Denny Rifsal Siregar. (2018); ASSOCIATION BETWEEN PLASMA VITAMIN D LEVEL AND METASTASIS IN BREAST CANCER., Int. J. of Adv. Res., 6 (08), 1017-1021, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/7606

Corresponding Author

Ira Astuti hasibuan
Biomedical Departement of Medical Faculty, Universitas Sumatera Utara
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.